Omega Healthcare Investors (OHI)

NYSE Real Estate Health Care REITs S&P MidCap 400
$48.19
+0.20 (+0.42%)
Close of Nov 06, 2026 · end-of-day data
Source: Omega Healthcare Investors's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$900.83M$908.38M$881.68M$928.83M$892.38M$1.06B$878.24M$949.74M$1.05B$1.19B
Operating income$559.95M$315.17M$497.59M$551.75M——————
Interest expense$164.10M$188.76M$192.46M$208.72M$223.39M$234.60M$233.24M$235.53M$221.72M$215.03M
Pre-tax income$384.33M$105.92M$296.51M$343.84M$162.33M$416.08M$436.14M$255.05M$428.66M$624.22M
Income tax$1.41M$3.25M$3.01M$2.84M$4.92M$3.84M$4.56M$6.25M$10.86M$14.75M
Net income$366.42M$100.42M$281.58M$341.12M$159.33M$416.74M$426.93M$242.18M$406.33M$590.18M
EBITDA$827.01M$602.76M$778.87M$853.43M——————
EPS (basic)$1.91$0.51$1.41$1.60$0.70$1.76$1.81$1.01$1.57$1.96
EPS (diluted)$1.90$0.51$1.40$1.58$0.70$1.75$1.80$1.00$1.55$1.94
Diluted shares201.63M206.79M209.71M222.12M235.10M244.34M244.29M250.45M270.45M304.95M
Operating margin62.2%34.7%56.4%59.4%——————
Net margin40.7%11.1%31.9%36.7%17.9%39.2%48.6%25.5%38.6%49.6%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$93.69M$85.94M$10.30M$24.12M$163.53M$20.53M$297.10M$442.81M$518.34M$27.02M
Goodwill$643.47M$644.69M$643.95M$644.41M$651.74M$651.42M$643.15M$643.90M$643.66M$644.63M
Total assets$8.95B$8.77B$8.59B$9.80B$9.50B$9.64B$9.41B$9.12B$9.90B$10.05B
Long-term debt$4.37B$4.57B$4.54B$5.14B$5.17B$5.25B$5.29B$5.07B$4.84B$4.26B
Total debt$4.37B$4.57B$4.54B$5.14B$5.17B$5.25B$5.29B$5.07B$4.84B$4.26B
Total liabilities$4.74B$4.89B$4.83B$5.46B$5.46B$5.53B$5.60B$5.36B$5.17B$4.61B
Shareholders' equity$3.86B$3.56B$3.44B$4.14B$3.84B$3.91B$3.61B$3.57B$4.54B$5.18B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$624.77M$577.91M$499.37M$553.75M$708.26M$722.14M$625.73M$617.74M$749.43M$878.55M
Capital expenditures$40.47M$37.77M$29.82M$52.89M$31.07M$44.95M$47.22M$38.01M$37.76M$80.87M
Free cash flow$584.30M$540.15M$469.55M$500.86M$677.18M$677.19M$578.51M$579.73M$711.67M$797.68M
Investing cash flow-$1.11B-$285.13M-$173.22M-$378.95M-$89.06M-$524.17M$442.85M-$770.00K-$671.16M-$539.79M
Financing cash flow$576.30M-$303.81M-$410.70M-$153.96M-$485.55M-$341.12M-$789.45M-$473.31M$26.32M-$838.26M
Dividends paid$453.15M$502.60M$528.70M$564.13M$612.31M$637.65M$632.89M$643.87M$685.45M$780.39M
Share buybacks——————$142.27M———
Stock-based compensation$13.79M$15.21M$15.99M$15.36M$18.82M$21.41M$27.30M$35.07M$36.70M$44.19M
Depreciation & amortization$267.06M$287.59M$281.28M$301.68M$329.92M$342.01M$332.41M$319.68M$304.65M$325.25M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.